Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

Recs

0
Player Avatar Academagogue (28.63) Submitted: 10/12/2006 2:33:53 PM : Outperform Start Price: $16.24 ALNY Score: -39.06

Nobel prize winning tech and the rights to control it.

Featured Broker Partners


Advertisement